Pharma market in good health; lifestyle diseases may be rising
The other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the ...
The Financial Express6 天
Glenmark Telma’s journey to Rs 1000cr becomes a Harvard case study
A 2015 study by Harvard Business Publishing Education revealed that Telma was introduced by Glenmark in 2003 at a time when ...